Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Centre for Process Innovation
Centre for Process Innovation
Activities:
Research & Development
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
KBI Biopharma extends contract with a big pharma giant after a successful FDA inspection
The contract has been renewed and extended until at least 2029, and will now include the purchase of two therapeutic products
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
New FAIRY viral assay could 'revolutionise' the response to future pandemics
The assay, which can detect the infectiousness of a virus in a matter of minutes, offers a quicker and cheaper alternative to the standard cell culture approach
New advice from BOLA and Labtex on cleaning and handling of PTFE products after use
The companies share: "Abrasive scouring agents may result in a milkiness of the vessels made of PFA and FEP. You may use all neutral detergents (pH 7). For higher contamination...
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Research & Development
Pfizer partners with Medicines Manufacturing Innovation Centre
The company will be participating in the centre’s first ‘grand challenge,’ aiming to develop a continuous direct compression platform for oral solid dosage medicines
Research & Development
MicrofluidX makes key collaboration for microfluidics platform
CPI, MicrofluidX and the Cell and Gene Therapy Catapult have collaborated to develop bioprocessing technology for the rapid scale-up of cell and gene therapies
CPI CEO passes the torch
Nigel Perry has stepped down as CEO and will be succeeded by COO, Frank Millar
Research & Development
CPI and Oxford University join forces to lower NADH production cost
A constant feed of the expensive cofactor NADH is a requirement in many biocatalytic reactions and this has hindered industrial adoption of the technology
Ingredients
Rapid formulation stability screening platform tests real-world use
Following two years of research by CPI at Imperial College London and the University of Durham, the project is now translating the academic work into real-world applications
Ingredients
Research partnership removes bottleneck from AAV development
CPI, Cobra Biologics and GE Healthcare Life Sciences have developed a scalable, cost-effective purification process for adeno-associated viruses
Manufacturing
Innovation centre works with pharma giants on continuous manufacturing
CPI and Strathclyde University’s strategic partnership with GSK and AstraZeneca has begun work on a continuous direct compression platform for oral solid dosage medicines
Subscribe now